文献速递骨显像与常规 SPECT肿瘤 PET/CT放射性药物与辐射防护

假体周围关节感染的分子影像学

Molecular Imaging of Periprosthetic Joint Infections.
PubMed 文献 · Semin Nucl Med · 2022-12-08

假体周围关节感染是下肢关节置换术的少见并发症,约三分之一在术后3个月内发生(早期),另三分之一在1年内发生(延迟),其余在1年以后发生(晚期)。诊断常需结合血液、滑液、组织样本检测及影像学。分子影像学对评估疼痛性关节置换有帮助,骨显像最适合作为筛查试验,联合标记白细胞/骨髓显像对诊断下肢关节置换感染特异性很高但敏感性多变,18F-FDG价值尚无共识,几种新型显像剂初步结果鼓舞但尚无大规模试验,监测治疗反应的数据极少。

要点

  • 疼痛是最常见症状,见于90%-100%的感染患者;发热比例从不足5%到超过40%不等。
  • 红细胞沉降率、C反应蛋白和白细胞介素-6水平是有用的排除试验,外周血白细胞计数和血清肿瘤坏死因子α无帮助。
  • 骨显像阴性时感染和无菌性松动可能性不大;联合标记白细胞/骨髓显像对下肢关节置换感染特异性很高但敏感性多变。

核心结论

  • 分子影像学对评估疼痛性关节置换有用;骨显像最适合作为筛查试验,阴性时感染和无菌性松动可能性不大;联合标记白细胞/骨髓显像对诊断下肢关节置换感染特异性很高但敏感性多变;18F-FDG诊断假体周围关节感染的价值仍无共识;几种新型显像剂初步结果鼓舞但尚无大规模试验;监测治疗反应的数据极少。

研究设计与样本

  • 本文为综述,检索范围未在原文摘要中报告。

主要发现

  • 感染约三分之一在术后3个月内发生(早期),另三分之一在1年内发生(延迟),其余在1年以后发生(晚期)。
  • 疼痛见于90%-100%的感染患者;发热比例从不足5%到超过40%不等;红斑和关节肿胀常见于急性感染,慢性感染较少见。
  • 红细胞沉降率、C反应蛋白和白细胞介素-6水平是有用的排除试验,外周血白细胞计数和血清肿瘤坏死因子α无帮助。
  • 骨显像最适合作为筛查试验,阴性时感染和无菌性松动可能性不大;联合标记白细胞/骨髓显像对诊断下肢关节置换感染特异性很高,敏感性多变。
  • 有限数据提示标记白细胞/骨髓SPECT/CT和18F-FDG-PET/CT对肩关节置换假体周围感染诊断特异性高但不敏感。

关键数值与推荐

  • 18F-FDG诊断假体周围关节感染尚无共识,障碍包括检验概率不同、无法区分感染与生理反应所致炎症、缺乏标准化判读标准。
  • 镓-68枸橼酸盐、氟-18和锝-99m标记抗菌片段初步结果鼓舞,但尚无大规模试验。
  • 监测假体周围感染治疗反应的分子影像数据极少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 18F-FDG诊断假体周围关节感染尚无共识,障碍包括检验概率不同、无法区分感染与生理反应所致炎症、缺乏标准化判读标准。
  • 镓-68枸橼酸盐、氟-18和锝-99m标记抗菌片段初步结果鼓舞,但尚无大规模试验。
  • 监测假体周围感染治疗反应的分子影像数据极少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection is an infrequent complication of lower extremity prosthetic joint surgery. Approximately one third develop within 3 months (early), another third within 1 year (delayed), and the remainder more than 1 year (late) after surgery. The diagnosis of periprosthetic joint infection is not always straightforward. Pain, the most common symptom, is present in 90%-100% of patients. The presence of fever is more variable, ranging from less than 5% to more than 40% of patients with infection. Erythema and joint swelling are often present in acute infections, but are less common in chronic infections. Erythrocyte sedimentation rate, C-reactive protein and interleukin-6 levels are useful "rule out" tests, while peripheral blood leukocyte count and serum tumor necrosis factor α are not helpful. The diagnosis of periprosthetic joint infection often requires a combination of blood, synovial fluid, and tissue sample tests, as well as imaging. Plain radiographs lack sensitivity and specificity. Molecular imaging is useful for evaluating painful joint replacements. Bone scintigraphy is most useful as a screening test. If it is negative then infection and aseptic loosening are unlikely. Combined labeled leukocyte/bone marrow imaging is a very specific test for diagnosing lower extremity joint arthroplasty infection; sensitivity is more variable. Despite more than two decades of investigation, there still is no consensus on the value of 18F-FDG for diagnosing periprosthetic joint infection. Differing test probabilities, an inability to discriminate between infection and inflammation secondary to physiologic reactions, and lack of standardized interpretative criteria are obstacles to incorporating 18F-FDG into the routine diagnostic imaging workup of periprosthetic joint infection. Preliminary results for gallium-68 citrate, fluorine-18, and technetium-99m labeled antimicrobial fragments are encouraging but no large scale trials with these agents have been conducted. Limited data suggest that labeled leukocyte/bone marrow SPECT/CT and 18F-FDG-PET/CT are specific but not sensitive for diagnosing periprosthetic infection of shoulder arthroplasties. There are minimal data on molecular imaging for monitoring treatment response in periprosthetic infections.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Palestro CJ. Molecular Imaging of Periprosthetic Joint Infections. Semin Nucl Med. 2022. PMID: 36496268. doi:10.1053/j.semnuclmed.2022.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。